William Burke - Aug 23, 2021 Form 4 Insider Report for HAEMONETICS CORP (HAE)

Role
EVP, Chief Financial Officer
Signature
/s/ Michelle Basil, attorney-in-fact for Mr. Burke
Stock symbol
HAE
Transactions as of
Aug 23, 2021
Transactions value $
-$511,180
Form type
4
Date filed
8/25/2021, 04:15 PM
Previous filing
Jul 6, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HAE Common Stock Options Exercise $384K +11.2K +37.08% $34.21 41.5K Aug 23, 2021 Direct F3
transaction HAE Common Stock Options Exercise $476K +11.4K +27.54% $41.64 53K Aug 23, 2021 Direct F3
transaction HAE Common Stock Sale -$1.37M -22.7K -42.8% $60.51 30.3K Aug 23, 2021 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -11.2K -100% $0.00* 0 Aug 23, 2021 Common Stock 11.2K $34.21 Direct F1
transaction HAE Non-qualified Stock Option (Right to Buy) Options Exercise $0 -11.4K -100% $0.00* 0 Aug 23, 2021 Common Stock 11.4K $41.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction pursuant to an existing 10b5-1 trading plan.
F2 Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 This number includes unvested RSUs previously reported.